FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

407092001: Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2150922011 Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2158715013 Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2150922011 Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2150922011 Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2158715013 Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2158715013 Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Is a Buprenorphine hydrochloride + naloxone hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Naloxone hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Substance with opioid receptor partial agonist mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Central nervous system agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Substance with chelating agent mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Buprenorphine hydrochloride (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Buprenorphine false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opiate agonist-antagonist false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Is a Product containing buprenorphine and naloxone (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Has manufactured dose form forme pharmaceutique pour usage oromucosal et/ou gingival false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Has manufactured dose form Sublingual tablet (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Is a Product containing naloxone in oropharyngeal dosage form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Is a Product containing buprenorphine in oropharyngeal dosage form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Is a Product containing buprenorphine and naloxone in oropharyngeal dosage form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Is a Product manufactured as oromucosal dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start